Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NYSE

Starwood Shares Have Struggled, but Catalysts Could Signal a Turn

Starwood Property Trust has lagged in recent years, but stronger earnings, improving dividend coverage and a new buyback could signal a turnaround.

Corrugated Cash Flow: Hiding in Packaging Stocks

Corrugated Cash Flow: Hiding in Packaging Stocks

During times of market volatility, industry leaders in the packaging sector showcase impressive pricing power and consistent shareholder returns.

Merck Just Made a Big Bet on a New Cancer Growth Engine

Merck Just Made a Big Bet on a New Cancer Growth Engine

Merck's $6.7 billion Terns acquisition bolsters its oncology pipeline while reinforcing its strong margins, steadily growing dividend, and long-term growth.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is NuScale's Plunge the Ultimate AI Contrarian Play?

NuScale Power's unique regulatory approvals and rock-solid financial position make it a key player in powering the future of the AI industry.

3 Investments With Solid Yields Powering Through Market Weakness

As the market sinks deeper into the red, these income-generating investments are performing well with paths toward upside potential ahead.

Three Oversold REITs With Strong Fundamentals

REITs have become a forgotten asset class during the AI boom years, but now that volatility has returned, this sector could be on the verge of a turnaround.

Can Capital One Prove Itself in 2026?

Capital One Financial enters 2026 at a critical juncture, as its Discover acquisition and rising credit risks test its ability to deliver sustained growth.

inkl

Read news from The Economist, FT, and more,
with one subscription

The Often-Missed Corner of Healthcare That Wall Street Is Loving

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

Financials Are Down Big This Year, but XLF Is Looking Like a Buy-Low Opportunity

Financials Are Down Big This Year, but XLF Is Looking Like a Buy-Low Opportunity

Despite high hopes for financials during Trump’s second term, the sector has performed the worst in the S&P 500 this year. But the XLF offers a buy-low entry.

Affirm: A Solid Footing or More Volatility Ahead?

Affirm: A Solid Footing or More Volatility Ahead?

Affirm stock is gaining attention as the buy-now-pay-later lender shows growth and improving profitability, but risks remain in credit quality and competition.

Why It's Not Time to Give Up on the Gold Trade

Why It's Not Time to Give Up on the Gold Trade

Gold’s pullback may be temporary as rising U.S. debt, inflation risks, and geopolitical tensions support a longer-term bullish outlook

Dividend Resilience: Why These Kings Are Safe After a Volatile Q1

Dividend Resilience: Why These Kings Are Safe After a Volatile Q1

In a volatile market, many investors are turning to these Dividend Kings that offer reliable income, strong balance sheets, and stability

Arm's New Gambit: Building Chips to Challenge the AI Titans

Arm's New Gambit: Building Chips to Challenge the AI Titans

Arm Holdings is fundamentally transforming its business model by launching its own in-house AI chip to capture a larger share of the data center market.

A Q2 2026 Playbook for Navigating Market Uncertainty

A Q2 2026 Playbook for Navigating Market Uncertainty

For investors looking to rebalance in Q2, here are three stocks that combine growth and defense to help investors stay invested during volatile markets

Get all your
news in one place.

100's of premium titles.
One news app.

5 Spin-Off Stocks That Could Reward Patient Investors in 2026

Spin-offs are a way for CEOs to unleash growth and unlock shareholder value; this is a look at five spin-offs that are getting bullish attention from analysts.

S&P 500 Rebalancing: 3 Key AI Stocks Earn Their Spot in the Index

See which stocks made the cut in the S&P 500's latest rebalancing and have now entered the index. This includes three AI names and two with backing from NVIDIA.

These 3 Defensive Stocks Just Hit 52-Week Highs — Should You Lock In Gains?

High PEG ratios indicate that many defensive stocks in health care and consumer staples trade at stretched valuations. With earnings growth lagging price momentum, three stand out as candidates for profit-taking while the market’s risk appetite begins to shift.

5 High-Yield Stocks to Shield Your Portfolio From the Storm

With the S&P 500 breaking below its 200-day SMA, high-yield dividend stocks are increasingly worth considering as a source of income and portfolio protection.

Get all your
news in one place.

100's of premium titles.
One news app.

Can SoFi Shares Thrive Through Maturity?

SoFi stock reflects a high-growth fintech story balancing strong user expansion, product innovation, and rising competitive and credit risks in digital banking.

Circle May Be the Biggest Winner of America’s Stablecoin Shift

The GENIUS Act formalized stablecoins and blocked a U.S. CBDC, giving Circle a privileged lane in U.S. payments infrastructure—and a new headwind for Bitcoin.

3 Natural Gas Names to Watch as a Global Supply Shock Builds

Natural gas prices may be set to rise due to LNG supply shocks; here are two stocks and an ETF positioned to benefit from tightening global supply

MarketBeat Week in Review – 03/16 - 03/20

This week, all the major indexes closed below their 200-day moving averages, meaning investors may have to wait a little longer for the stock selloff to end

What a Gold Miner and an Oil Trust Reveal About Today’s Market

The market rotation into energy and materials is accelerating as the bull market matures, with geopolitical unrest fueling the rallies in gold and oil.

The SkyWater Deal: IonQ's Bid for Quantum Supremacy

IonQ made one of the biggest moves in the quantum computing industry during 2026. Its acquisition of SKYT could be huge for its quantum development roadmap.

The Copper Barbell: How to Profit From the Shortage—and Avoid the Dilution Trap

Compare copper producers, COPX, and select developers as deficits tighten: key operational risks, dilution traps, and what support actually changes.

1 2 3 4 5

People

178,069 stories

Jeffrey Neal Johnson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

357,819 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play